Inventor
CAGGIANO ANTHONY O
US34 patents
⚠️ This page may combine multiple inventors who share the name “CAGGIANO ANTHONY O”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ACORDA THERAPEUTICS INC
25 patentsUS9198951B2Dec 1, 2015
Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure
ACORDA THERAPEUTICS INC10 citations81
US7722864B2May 25, 2010
Compositions and methods of using chondroitinase ABCI mutants
ACORDA THERAPEUTICS INC3 citations73
US7485295B2Feb 3, 2009
Compositions and methods of using chondroitinase ABCI mutants
ACORDA THERAPEUTICS INC4 citations72
US11141467B2Oct 12, 2021
Methods of reducing extravasation of inflammatory cells
ACORDA THERAPEUTICS INC2 citations71
US9757429B2Sep 12, 2017
Methods for detecting cardiac damage
ACORDA THERAPEUTICS INC2 citations71
US9956266B2May 1, 2018
Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure
ACORDA THERAPEUTICS INC2 citations70
US9410141B2Aug 9, 2016
Compositions and methods of using chondroitinase ABCI mutants
ACORDA THERAPEUTICS INC2 citations62
US9102930B2Aug 11, 2015
Compositions and methods of using chondroitinase ABCI mutants
ACORDA THERAPEUTICS INC2 citations62
US7731956B2Jun 8, 2010
Compositions and methods of using chondroitinase ABCI mutants
ACORDA THERAPEUTICS INC2 citations61
US11071770B2Jul 27, 2021
Methods for detecting cardiac damage
ACORDA THERAPEUTICS INC0 citations60
US9329171B2May 3, 2016
Methods for detecting cardiac damage
ACORDA THERAPEUTICS INC2 citations60
US9272015B2Mar 1, 2016
Method for achieving desired glial growth factor 2 plasma levels
ACORDA THERAPEUTICS INC1 citations60
US7968089B2Jun 28, 2011
Proteoglycan degrading mutants for the treatment of CNS
ACORDA THERAPEUTICS INC2 citations60
US7959914B2Jun 14, 2011
Methods of reducing extravasation of inflammatory cells
ACORDA THERAPEUTICS INC2 citations60
US11235031B2Feb 1, 2022
Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure
ACORDA THERAPEUTICS INC0 citations59
US9987340B2Jun 5, 2018
Compositions and methods of using chondroitinase ABCI mutants
ACORDA THERAPEUTICS INC0 citations51
US10323240B2Jun 18, 2019
Compositions and methods of using chondroitinase ABCI mutants
ACORDA THERAPEUTICS INC0 citations50
US10258667B2Apr 16, 2019
Methods for detecting cardiac damage
ACORDA THERAPEUTICS INC0 citations50
US9839679B2Dec 12, 2017
Methods of reducing extravasation of inflammatory cells
ACORDA THERAPEUTICS INC0 citations50
US9834764B2Dec 5, 2017
Compositions and methods of using chondroitinase ABCI mutants
ACORDA THERAPEUTICS INC0 citations50
US9402886B2Aug 2, 2016
Compositions and methods of using chondroitinase ABCI mutants
ACORDA THERAPEUTICS INC0 citations50
US10675331B2Jun 9, 2020
Method for achieving desired glial growth factor 2 plasma levels
ACORDA THERAPEUTICS INC0 citations49
US9744215B2Aug 29, 2017
Method for achieving desired glial growth factor 2 plasma levels
ACORDA THERAPEUTICS INC0 citations49
US9528102B2Dec 27, 2016
Proteoglycan degrading mutants for treatment of CNS
ACORDA THERAPEUTICS INC0 citations49
US7429375B2Sep 30, 2008
Proteoglycan degrading mutants for the treatment of CNS
ACORDA THERAPEUTICS INC0 citations49
CAGGIANO ANTHONY O
5 patentsUS8404232B2Mar 26, 2013
Compositions and methods of using chondroitinase ABCI mutants
CAGGIANO ANTHONY O2 citations61
US8852583B2Oct 7, 2014
Compositions and methods of using chondroitinase ABCI mutants
CAGGIANO ANTHONY O2 citations60
US8236302B2Aug 7, 2012
Compositions and methods of using chondroitinase ABCI mutants
CAGGIANO ANTHONY O2 citations60
US8226941B2Jul 24, 2012
Methods of purifying chondroitinase and stable formulations thereof
CAGGIANO ANTHONY O2 citations53
US9078861B2Jul 14, 2015
Use of a neuregulin to treat peripheral nerve injury
CAGGIANO ANTHONY O0 citations43